Cleaning house
21 ViewsWith drug pricing a priority for the US Biden administration, the biotech industry must clean up its act: stop profiteering from old products and stamp out anticompetitive practices. Late last year, the US Trump administration announced its Most Favored Nation (MFN) model for drug pricing, aiming to align Medicare’s …